Mutations in RAB27A cause Griscelli syndrome associated with haemophagocytic syndrome
Gaël Ménasché(Inserm), Geneviève de Saint Basile(Inserm), Nico Wulffraat(Utrecht University), Jérôme Feldmann(Inserm), Diana W. Bianchi(National Human Genome Research Institute), Sophie Dupuis(Hôpital Necker-Enfants Malades), Stéphanie Certain(Inserm), Fügen Ersoy(Hacettepe University Hospital), Alain Fischer(Inserm), Françoise Le Deist(Centre National de la Recherche Scientifique), Élodie Pastural(Inserm)
Cited by 951
Related Papers
<i>LMO2</i> -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1
|Science|2003|3.5k
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
|Science|2020|3.2k
Gene Therapy of Human Severe Combined Immunodeficiency (SCID)-X1 Disease
|Science|2000|2.6k
A Serious Adverse Event after Successful Gene Therapy for X-Linked Severe Combined Immunodeficiency
|New England Journal of Medicine|2003|1.8k
Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1
|Journal of Clinical Investigation|2008|1.8k